SERPINA1 and dementia: We speculate that the CSF serpinA1 isoform analysis by the novel CIEF-immunoassay may turn out to have value for the biomarker supported prediction of cognitive impairment, as the serpinA1 isoform pattern might already be altered at a pre-dementia stage in PD patients who will develop PDD.